Single Gene Disorders Disorders of Epigenetic Machinery

Slide 1 · Single-Gene Disorders

Disorders of Epigenetic Machinery

Chromatin regulation, Mendelian disease and Rett syndrome

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain how chromatin state controls access to DNA without changing its sequence.

Distinguish epigenetic writers, erasers, readers, and chromatin-remodeling factors.

Connect MECP2 dysfunction to Rett syndrome and its clinical trajectory.

Interpret the inheritance and phenotypic heterogeneity of this disease group.

Slide 3 · An additional mechanism of Mendelian disease

Conventional examples

Epigenetic machinery

Structural proteins alter tissue integrity.

Transport proteins alter molecular movement.

Enzymes interrupt metabolic pathways.

The primary lesion affects regulation of gene activity.

Multiple downstream genes can become misregulated.

Effects depend on cellular lineage and development.

The genetic lesion is in a single gene; Downstream expression effects may be broad.

Slide 4 · DNA sequence and epigenetic state are distinct

Inherited variant

Changes the sequence of a gene encoding a regulator

Defective regulator

Alters chromatin marking or accessibility

Gene-expression disturbance

Impairs cell and tissue function

A sequence variant can cause disease by altering control of other genes.

Slide 5 · Why cells with similar DNA have different functions

Shared genome

Lineage-specific expression

Most differentiated somatic cells carry essentially the same DNA sequence.

The sequence alone does not specify a single cell phenotype.

Different genes are transcriptionally available in different cells.

Chromatin organization helps maintain cell identity.

Epigenetic organization contributes to cell type–specific transcription.

Slide 6 · What is an epigenetic state?

A chemical state associated with DNA or DNA-bound proteins.

Influences DNA packaging and transcriptional availability.

May be modified without altering the underlying base sequence.

Its functional effect depends on genomic location and context.

Slide 7 · Chromatin accessibility is a functional spectrum

Euchromatin

Heterochromatin

Relatively dispersed chromatin.

DNA is generally more accessible to transcription factors.

Often associated with actively transcribed genes.

More compact chromatin.

Access to regulatory DNA is restricted.

Often associated with transcriptional inactivity.

“Open” and “closed” summarize relative access, not an absolute binary.

Slide 8 · Chromatin architecture shapes transcription

Histone-bound DNA

Nucleosomes package the DNA

Accessible regulatory site

Transcriptional machinery can engage

Gene expression

RNA synthesis becomes possible

Nucleosome placement and marks influence whether regulatory sequences can be used.

Slide 9 · A nucleosome is the basic repeating unit

Histone core

Histone core

Histone core

Histone core

Histone core

DNA wrapping around histone cores, connected by linker DNA

DNA wraps around a core histone octamer.

Successive nucleosomes are connected by linker DNA.

The repeating DNA–histone structure forms chromatin.

Slide 10 · The histone octamer has a defined composition

H2A

Two copies

H2B

Two copies

H3

Two copies

H4

Two copies

The nucleosome core contains eight histone proteins: Two of each type.

Slide 11 · Linker DNA and histone H1 support packing

DNA links neighboring nucleosome core particles.

Histone H1 associates with linker DNA and supports higher-order organization.

Higher-order packaging changes access to transcriptional control sites.

Slide 12 · Position matters: A promoter can be exposed or obscured

Accessible promoter

Occluded promoter

Regulatory DNA is less occluded by nucleosomes.

Transcription factors can more readily bind.

Nucleosome position restricts physical access.

Initiation of transcription is less favored.

The schematic describes chromatin accessibility; It is not a quantitative assay.

Slide 13 · Chromatin remodelers reposition nucleosomes

Nucleosome placement

A promoter or enhancer is covered

Remodeling complex

Repositions nucleosomes on DNA

Changed accessibility

Regulatory factors gain or lose access

A remodeler changes positioning; It is not synonymous with adding a chemical mark.

Slide 14 · DNA methylation marks cytosine at CpG sites

C

G

C

G

C

G

C

G

Methyl marks on selected cytosines (schematic)

The major DNA mark discussed by Robbins is 5-methylcytosine.

Methylation occurs at the C5 position of cytosine.

CpG denotes cytosine followed by guanine along a DNA strand.

Slide 15 · DNA methylation can repress regulatory regions

CpG methylation

Mark at a gene regulatory region

Methylated-DNA readers

Proteins recognize the modified CpG

Silencing machinery

Chromatin becomes less transcriptionally permissive

High methylation in gene regulatory elements typically associates with silencing.

Slide 16 · The position of an epigenetic mark changes its meaning

Regulatory-region DNA methylation commonly correlates with gene silencing.

Histone methylation can activate or repress depending on the modified residue.

It is inaccurate to label all “methylation” simply as activating or silencing.

Slide 17 · Histone modifications constitute a regulatory code

Histone proteins undergo covalent posttranslational modifications.

Acetylation, methylation, and phosphorylation are discussed.

Combinations of modifications influence chromatin structure and transcription.

Slide 18 · Histone acetylation generally favors open chromatin

Histone lysine acetylation

Acetyl groups are added

Less compact configuration

Transcription-factor access is favored

Higher transcriptional potential

Permissive chromatin state

This is a tendency, not proof that every acetylated locus is transcriptionally active.

Slide 19 · Histone acetyltransferases are epigenetic writers

Histone substrate

Lysine residues are available

HAT activity

Transfers an acetyl group

Acetylated chromatin

Frequently more permissive to transcription

A writer installs a mark; The consequence depends on the marked site.

Slide 20 · Histone deacetylases remove acetyl marks

Acetylated histone

Acetyl marks are present

HDAC activity

Removes acetyl groups

Chromatin compaction

Transcription is often less favored

Deacetylation is one mechanism by which silencing complexes act.

Slide 21 · Histone methylation is residue dependent

Activating context

Repressive context

Methylation of certain histone residues is associated with active transcription.

The target residue must be specified to infer function.

Methylation at other residues is associated with condensed chromatin.

“Histone methylation” alone does not predict direction.

Avoid treating histone methylation as equivalent to CpG methylation.

Slide 22 · Histone phosphorylation is context dependent

Specific histone serines can be phosphorylated.

The effect depends on the modified site and biological context.

Phosphorylation may accompany either accessible or condensed chromatin.

Slide 23 · Three classes of mark-handling proteins

Writers

Install chemical marks on DNA or histones.

Erasers

Remove previously installed chemical marks.

Readers

Recognize marks and recruit effectors.

Chromatin remodelers form a related functional category that changes nucleosome positioning.

Slide 24 · Writers alter the information carried by chromatin

Writer gene mutation

Mark installation may be perturbed

Altered mark landscape

Regulatory regions may be misconfigured

Expression consequences

Cell programs may be disrupted

Effects vary by gene, affected mark, and tissue.

Slide 25 · Erasers make chromatin states reversible

Existing histone mark

Chromatin carries a modification

Eraser removes mark

Mark balance can change

Regulatory state shifts

Transcriptional access may change

A loss of eraser function may disrupt normal chromatin transitions.

Slide 26 · Readers translate chemical marks into regulatory actions

Marked DNA or histone

Specific chemical signature

Reader protein

Binds a recognized mark

Effector complex

Changes chromatin structure or transcription

MeCP2 illustrates a reader of methylated CpG DNA.

Slide 27 · Remodelers regulate placement rather than mark chemistry

Chemical-mark machinery

Chromatin remodeling

Writer: Adds a modification.

Eraser: Removes a modification.

Reader: Interprets a modification.

Changes nucleosome position on DNA.

Alters exposure of promoters and enhancers.

May work together with mark-dependent complexes.

Slide 28 · Epigenetic control is an integrated system

Chromatin accessibility and gene expression

DNA methylation

Histone marks

Nucleosome position

Reader/corepressor

Integrated control: Marks, readers, and remodelers are complementary mechanisms.

Slide 29 · Why a single mutation may affect many genes

One regulator is defective

Its normal targets are not correctly controlled

Multiple regulatory loci

Gene-expression patterns may be altered

Developmental phenotypes

Different organs and neural circuits may be affected

The reach of the mechanism explains clinical breadth; It does not imply every target is affected identically.

Slide 30 · Mendelian epigenetic disorders are heterogeneous

Different causal genes affect writers, erasers, readers, or remodelers.

Clinical manifestations vary across affected genes.

Many syndromes involve neurologic dysfunction and intellectual disability.

A shared regulatory mechanism does not imply a single clinical phenotype.

Slide 31 · Most reported syndromes follow a dominant pattern

Many epigenetic-machinery disorders as autosomal dominant.

Rett syndrome is an important X-linked exception.

Inheritance depends on the gene and specific pathogenic variant.

Slide 32 · Why neurodevelopment is frequently involved

Developing nervous system

Needs timed, lineage-specific gene programs

Chromatin regulators

Coordinate access to many loci

Regulatory disturbance

Can affect neural development and function

A mechanistic interpretation consistent with the neurologic predominance.

Slide 33 · Examples in the Mendelian epigenetic group

Syndrome named in Robbins

Teaching point

Kabuki syndrome

Example of a Mendelian disorder involving epigenetic regulation

Wilson–Turner syndrome

Included among genetically heterogeneous epigenetic disorders

Weaver syndrome

Part of the listed spectrum

Rubinstein–Taybi syndrome

Illustrates syndromic neurodevelopmental involvement

Smith–Magenis syndrome

Another syndrome in the textbook grouping

Slide 34 · Phenotypic variation does not invalidate a common mechanism

Shared pathway level

Different clinical outcomes

Abnormal regulation of chromatin and gene expression.

Mutations can involve mark addition, removal, recognition, or remodeling.

Affected proteins act at different loci and developmental stages.

Features can vary across organ systems and age.

The disease group is mechanistically related, not phenotypically uniform.

Slide 35 · Do not equate an epigenetic disorder with a DNA methylation defect

Broad disease class

Specific molecular lesion

Histone writers and erasers.

Histone or DNA-mark readers.

Chromatin-positioning machinery.

Rett syndrome primarily involves the reader MeCP2.

The responsible gene is MECP2.

The defect is not simply “too much methylation.”

Slide 36 · Rett syndrome is the textbook prototype

Rett syndrome illustrates a single-gene defect of epigenetic reading.

An X-linked MECP2-related condition.

Classically recognized after initially unremarkable early development.

Its characteristic phenotype evolves through developmental stagnation and regression.

Slide 37 · MECP2 encodes a methyl-CpG-binding protein

MECP2 gene

X-linked gene

MeCP2 protein

Recognizes methylated CpG DNA

Chromatin regulation

Recruits transcription-silencing factors

Gene symbol MECP2; Protein name MeCP2.

Slide 38 · MeCP2 binds a chemical signal on DNA

DNA containing methylated CpG

MeCP2 DNA reader

Specific recognition of a DNA methylation mark permits recruitment of downstream factors.

Slide 39 · MeCP2 connects methylated DNA to corepressors

Methylated CpG

DNA epigenetic mark

MeCP2

Methyl-DNA reader

MSIN3A and HDACs

Corepressor machinery

This depicts the repressive mechanism illustrated Fig. 5.18.

Slide 40 · MSIN3A and HDACs cooperate in transcriptional repression

MeCP2 recruitment

Reader binds methylated CpG

MSIN3A scaffold

Corepressor components assemble

HDAC activity

Histone acetyl marks are removed

Deacetylation helps establish less permissive chromatin.

Slide 41 · Normal MeCP2 supports controlled silencing

Methylated CpG

MeCP2 can recognize the mark

Silencing factors

MSIN3A and HDAC activity are recruited

Heterochromatin tendency

Transcription is repressed at affected loci

Simplified textbook mechanism; Transcriptional effects are locus specific.

Slide 42 · Loss of MeCP2 disrupts interpretation of methylated DNA

Functional MeCP2

MeCP2 loss of function

Recognizes methylated CpG DNA.

Helps recruit chromatin-silencing machinery.

Contributes to normal regulatory control.

The mark cannot be interpreted normally by MeCP2.

Recruitment of effectors is perturbed.

Gene regulation becomes abnormal.

Do not infer that all genomic sites become uniformly derepressed.

Slide 43 · Rett syndrome reflects a defect in reading, not DNA sequence copying

What is altered?

What follows?

The protein responsible for reading a DNA mark is deficient.

The underlying methylated CpG remains a conceptually distinct feature.

Altered coordination between DNA marks and chromatin complexes.

Abnormal regulation of gene-expression programs.

Slide 44 · Rett syndrome has an X-linked molecular basis

MECP2 is located on the X chromosome.

The classic presentation mainly in girls.

MeCP2-related disease is also recognized in hemizygous males.

Sex-linked genotype and phenotype should not be conflated.

Slide 45 · Reported frequency is a context, not a screening test

Rett syndrome affects approximately 1 in 10,000 female births.

That estimate does not establish the probability for an individual patient.

The clinical phenotype and molecular basis must be assessed together.

Slide 46 · The early developmental history is diagnostically informative

Perinatal period

Classically unremarkable

Early infancy

Initial acquired milestones

Later infancy / childhood

Stagnation then regression

The sequence describes the classic presentation, not every possible MECP2 phenotype.

Slide 47 · Neurodevelopmental stagnation precedes loss of skills

Development

Early gains in function

Stagnation

Acquisition of new skills slows or stops

Regression

Previously acquired abilities are lost

Stagnation and regression are different clinical observations.

Slide 48 · Loss of purposeful hand use is a core clinical clue

Previously acquired ability

Classic Rett evolution

Purposeful manual activity develops in early childhood.

Hand use contributes to everyday learned tasks.

Purposeful hand movement is lost.

Stereotyped wringing and clasping may appear.

Slide 49 · Hand stereotypies have specific descriptive value

Repetitive hand wringing and clasping.

The movements accompany loss of purposeful manual function.

Both observations should be described rather than reduced to “abnormal movements.”

Slide 50 · Speech regression indicates broader neurodevelopmental loss

Children may lose speech abilities that were previously acquired.

Language loss occurs alongside motor and behavioral changes.

The combination signals a regressive developmental process.

Slide 51 · Motor dysfunction progresses beyond hand movements

Loss of acquired motor skills is part of the classic presentation.

Abnormal gait and ataxia may develop.

Clinical evaluation must consider changing motor function over time.

Slide 52 · Breathing abnormalities and seizures expand the phenotype

Respiratory manifestations

Neurologic manifestations

Breathing problems may occur.

The finding broadens the disorder beyond motor and language domains.

Seizures may develop.

The syndrome encompasses progressive neurologic dysfunction.

Slide 53 · Microcephaly and developmental dysfunction may coexist

Microcephaly is included in the classic syndrome description.

It accompanies progressive neurologic dysfunction rather than defining the entire syndrome.

The evolution of milestones remains central to recognizing the phenotype.

Slide 54 · Rett syndrome in males has a wider recognized spectrum

Historical assumption

Textbook update

MeCP2 mutations were once regarded as incompatible with life in hemizygous males.

Affected males are now recognized.

Phenotypes range from severe congenital encephalopathy to intellectual disability.

An affected male should not be excluded on sex alone.

Slide 55 · Clinical recognition requires a trajectory, not a single symptom

Early developmental history

Determine previously acquired milestones

Change in function

Identify stagnation or regression

Associated findings

Examine hand, gait, breathing and seizures

Mechanistic suspicion is strengthened by the combination and evolution of signs.

Slide 56 · Teaching case: Identify the unifying syndrome

Clinical vignette

A young girl initially acquires developmental milestones. Subsequently, language and purposeful hand use regress, repetitive hand-wringing develops, and walking becomes abnormal.

What syndrome and affected epigenetic reader best explain this pattern?

Slide 57 · Case explanation: Trace the molecular lesion

MECP2 pathogenic variant

Functional MeCP2 becomes deficient

Methyl-CpG recognition

Recruitment of silencing partners is disturbed

Neural gene regulation

Developmental and functional programs are affected

Clinical findings do not permit prediction of specific altered target genes from this textbook account.

Slide 58 · Epigenetic disease versus an enzyme-storage disease

Enzyme defect

Epigenetic regulator defect

A metabolic reaction is interrupted.

Upstream substrates may accumulate.

Pathologic storage or substrate toxicity may result.

A regulatory protein is impaired.

Chromatin state or mark interpretation is disturbed.

Multiple transcriptional programs may be affected.

Both can be single-gene disorders, but their proximal mechanisms differ.

Slide 59 · Mendelian epigenetic disease versus complex disease

Mendelian epigenetic syndrome

Complex multigenic disorder

A pathogenic variant in one regulator can be causative.

Inheritance is gene-dependent; Many are dominant.

Multiple inherited variants interact with other factors.

No single-gene lesion necessarily explains the phenotype.

Mechanistic grouping and inheritance grouping answer different questions.

Slide 60 · Three interpretation errors to avoid

Chemistry ≠ outcome

Not every methyl group represses transcription.

One gene ≠ one target

A regulator can influence many gene-expression programs.

X-linked ≠ girls only

MECP2-associated disease occurs in males as well.

Slide 61 · Second case: Which functional class is deficient?

Clinical vignette

Methylation remains a recognizable DNA modification, but a mutant protein can no longer bind methylated CpG and recruit chromatin-silencing factors.

Is the primary lesion in a writer, eraser, reader, or nucleosome remodeler?

Slide 62 · Diagnostic synthesis: From phenotype to mechanism

Clinical pattern

Developmental regression and characteristic findings

Gene-level inference

Consider MECP2 involvement

Molecular mechanism

Defective methyl-CpG reading and repression

Teaching linkage, not a replacement for a clinical diagnostic protocol.

Slide 63 · Key mechanistic conclusions

Epigenetic marks help establish transcriptionally permissive or repressive chromatin.

Writers, erasers, readers, and remodelers operate at different regulatory steps.

Mendelian disruption of one regulator can have broad developmental effects.

MeCP2 loss illustrates defective interpretation of methylated DNA in Rett syndrome.

Slide 64 · Key clinical conclusions

Many Mendelian epigenetic disorders feature neurologic dysfunction.

The classic Rett pattern combines early developmental gains, stagnation, and regression.

Loss of purposeful hand use, stereotypies, speech and gait abnormalities are discriminating clues.

MECP2-associated disease is recognized in both females and males.

Slide 65 · References

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 5, “Genes and Human Diseases,” including “Disorders of Epigenetic Machinery.”

Robbins, Cotran & Kumar. Pathologic Basis of Disease. 11th ed. Chapter 1, “Histone Organization.”

Textbook conceptual mechanism: Fig. 5.18 (Rett syndrome / MeCP2); original figure not reproduced.